Literature DB >> 23964648

Survival and prognostic factors of allogeneic hematopoietic stem cell transplant recipients admitted to intensive care unit.

Anne-Sophie Moreau1, Amélie Seguin, Virginie Lemiale, Ibrahim Yakoub-Agha, Patrick Girardie, Laurent Robriquet, Jacques Mangalaboyi, François Fourrier, Mercé Jourdain.   

Abstract

Mesh：

Year:  2013        PMID： 23964648     DOI： 10.3109/10428194.2013.836602

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  Acute kidney injury in critically ill allo-HSCT recipients.

Authors:  E Canet; E Lengline; L Zafrani; M-N Peraldi; G Socié; E Azoulay
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

Review 2.  Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.

Authors:  C Saillard; D Blaise; D Mokart
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

3.  Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en réanimation onco-hématologique (Grrr-OH) study.

Authors:  Virginie Lemiale; Matthieu Resche-Rigon; Djamel Mokart; Frederic Pène; Antoine Rabbat; Achille Kouatchet; François Vincent; Fabrice Bruneel; Martine Nyunga; Christine Lebert; Pierre Perez; Anne-Pascale Meert; Dominique Benoit; Sylvie Chevret; Elie Azoulay
Journal:  Ann Intensive Care       Date:  2015-09-30       Impact factor: 6.925

4.  Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospital.

Authors:  Jorge Garcia Borrega; Jan-Michel Heger; Matthias Kochanek; Dennis A Eichenauer; Philipp Koehler; Udo Holtick; Michael Hallek; Christof Scheid; Boris Böll; Alexander Shimabukuro-Vornhagen
Journal:  Ann Hematol       Date:  2021-10-20       Impact factor: 3.673
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.